Labcorp Holdings Inc.
Labcorp Holdings Inc. (LH) is a clinical laboratory services company with direct executive branch exposure via two Trump administration holdings and active congressional trading, but minimal lobbying, no federal contracts, and zero corporate insider buys in 180 days.
BusinessWhat LH does
Labcorp operates one of the largest clinical laboratory networks in the US, providing diagnostic testing services, drug development support via central lab services, and comprehensive laboratory management for hospitals and health systems. Revenue is primarily generated from routine and esoteric testing for patients, clinical trials, and managed care organizations.
12 months past · 3 months futureLH activity timeline
Executive Branch ConflictsLH held by Trump-administration officials
Lifetime Government AwardsLH federal contracts
LH doesn't hold direct federal contracts.
Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.
Smart Money · 13F HoldingsHedge funds holding LH
Politicians Trading LHMembers of Congress with recent LH positions
Congressional TradesWho in Congress is trading LH
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
Stock awards & option exercises
Bills Affecting LHLive legislation impacting this stock
Political ProfileWhere LH sits in Washington
[object Object]
STRUCTURAL: High regulatory density (8 healthcare bills, impact_ratio 0.0007 each) and executive branch exposure (2 filers, 3 holdings). EVIDENTIARY: Active congressional trading (3 politicians, 8 buys vs 7 sales) but zero corporate insider buys (tier F, 0 buys) and no lobbying spend ($0). Net: Mixed signals with no clear directional push.
Regulatory ExposureThreats & opportunities
Regulatory threats
-
Potential legislative changes impacting healthcare reimbursement or lab testing regulationsCongress, CMS"Recent bill_impacts array shows 8 healthcare bills with consistent impact_ratio 0.0007, each with estimated revenue impact ~$15-16M."
Regulatory opportunities
-
Limited direct opportunity signals; executive branch holdings may indicate administrative familiarityExecutive Office of the President"get_executive_branch_exposure.by_ticker shows two holdings by Donald J. Trump and one by Pete Hegseth."
Capitol Hill AlliesChampions & critics
Congressional champions
Congressional critics
Live signals + predictions for LH — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades LH
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord